BE414925A - - Google Patents
Info
- Publication number
- BE414925A BE414925A BE414925DA BE414925A BE 414925 A BE414925 A BE 414925A BE 414925D A BE414925D A BE 414925DA BE 414925 A BE414925 A BE 414925A
- Authority
- BE
- Belgium
- Prior art keywords
- insulin
- hydrochloride
- water
- protein
- clupeine
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 40
- 102000004877 Insulin Human genes 0.000 claims description 20
- 108090001061 Insulin Proteins 0.000 claims description 20
- 229940125396 insulin Drugs 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 108010040512 Clupeine Proteins 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 3
- 241000252203 Clupea harengus Species 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000000320 mechanical mixture Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE414925A true BE414925A (enrdf_load_stackoverflow) |
Family
ID=78155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE414925D BE414925A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE414925A (enrdf_load_stackoverflow) |
-
0
- BE BE414925D patent/BE414925A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2141704C (fr) | Solutions aqueuses concentrees d'argatroban | |
| Shinohara et al. | Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status | |
| EP0037318B1 (fr) | Nouvelles compositions utiles notamment dans le traitement et la prévention des pellicules et contenant des dérivés métalliques de l'acide thiobenzoique | |
| EP0416969B1 (fr) | Nouvelles émulsions eau dans huile et leur application à l'élimination du sulfure d'hydrogène | |
| BE1001527A6 (fr) | Preparation aqueuse stabilisee d'acide folique. | |
| BE414925A (enrdf_load_stackoverflow) | ||
| WO1987006130A1 (fr) | Comprimes a matrice | |
| US5847110A (en) | Method of reducing a schiff base | |
| FR2788436A1 (fr) | Composition d'un derive de phenothiazine | |
| FR2604900A1 (fr) | Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation | |
| FR2593394A1 (fr) | Procede de preparation de liposomes contenant une subtance active lipophile, notamment de l'amphotericine, liposomes et nouveau medicament obtenus | |
| CA1028243A (en) | Process for the preparation of blue maneb | |
| FR2741266A1 (fr) | Stimulation du metabolisme cellulaire par une proteine fixant reversiblement l'oxygene, celle-ci permettant la potentialisation de l'activite d'autres substances a vocation therapeutique ou cosmetique | |
| Greenwood | A partial purification and some properties of the cytochrome oxidase from pig-heart muscle | |
| EP0373993B1 (fr) | Procédé de préparation de composés énoliques et nouveaux produits obtenus | |
| FR2660196A1 (fr) | Procede de fabrication d'extrait cellulaire hydrosoluble d'embryons d'óoeuf et produit obtenu. | |
| CA1095067A (fr) | Sels d'hydrocarbyl-thio-ethylamines et leurs applications | |
| Laroche et al. | Ceruloplasmin: experimental anti-inflammatory activity and physicochemical properties | |
| FR2566661A1 (fr) | Methode pour dissoudre la griseofulvine en vue de preparer une solution de cette substance pour applications locales, qui soit chimiquement stable et douee d'activite biologique | |
| WO2024112515A1 (en) | Click chemistry ligand | |
| BE431123A (enrdf_load_stackoverflow) | ||
| FR2721315A1 (fr) | Dérivés de l'acide guanylique et applications comme médicaments. | |
| JP2001226259A (ja) | 酸化的劣化を防止した薬学的製剤を調製する方法、酸化的劣化を防止した食品を調製する方法 | |
| CH645120A5 (fr) | Procede de preparation de sulfate de vindesine. | |
| CH270687A (fr) | Procédé d'obtention d'un composé organique du soufre et du mercure. |